Ichikawa, Hitoshi

KIF5B-RET fusions in lung adenocarcinoma

Kohno, T., Ichikawa, H., Totoki, Y., Yasuda, K., Hiramoto, M., Nammo, T., Sakamoto, H., Tsuta, K., Furuta, K., Shimada, Y., et al. (2012) · Nature Medicine

Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics

Cited by 834

p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis

Kawase, T., Ichikawa, H., Ohta, T., Nozaki, N., Tashiro, F., Ohki, R., & Taya, Y. (2008) · Oncogene

Cancer-related Molecular PathwaysCell death mechanisms and regulation

Cited by 105

Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer

Hayashi, H., Kohno, T., Ueno, H., Hiraoka, N., Kondo, S., Saito, M., Shimada, Y., Ichikawa, H., Kato, M., Shibata, T., et al. (2017) · Pancreas

Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics

Cited by 88

PML-Retinoic Acid Receptor α Inhibits PML IV Enhancement of PU.1-Induced C/EBPε Expression in Myeloid Differentiation

Yoshida, H., Ichikawa, H., Tagata, Y., Katsumoto, T., Ohnishi, K., Akao, Y., Naoe, T., Pandolfi, P. P., & Kitabayashi, I. (2007) · Molecular and Cellular Biology

Retinoids in leukemia and cellular processesAcute Myeloid Leukemia Research

Cited by 45

Mammalian Nemo-like kinase enhances .BETA.-catenin-TCF transcription activity in human osteosarcoma and neuroblastoma cells

YASUDA, J., & ICHIKAWA, H. (2007) · Proceedings of the Japan Academy, Series B

Wnt/β-catenin signaling in development and cancerSignaling Pathways in Disease

Cited by 6